Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Re-recognition of Wholly-owned Subsidiaries as High-tech Enterprises

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 1 page · Chinese

Summary by 6ix AI

Hunan Fangsheng Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary, Yunnan Fuya Biotechnology Co., Ltd., has been re-recognized as a high-tech enterprise by relevant authorities.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Re-recognition of Wholly-owned Subsidiaries as High-tech Enterprises

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases